Our Story

Chanelle McCoy Health shares a passion for science innovation.

Chanelle, Lady McCoy and Caroline Glynn have worked together for 11 years in a global pharmaceutical company, where they developed the medical business, penetrating across 96 markets and achieving multiple medicines licences. Over the years they have built up superb regulatory expertise, operational & supply chain knowledge and an extensive pharmaceutical network.

As an R&D led company, Chanelle McCoy Health has spent five years, and a number of millions developing its Pureis® CBD food supplement product. It is the 1st CBD food supplement on the market that is clinically proven to be safe, and it is the 1st CBD food supplement on the market GLOBALLY using FDA registered raw material with 0% THC. Pureis® CBD is an Ultra Pure CBD.

For more details on Pureis® Ultra Pure CBD visit https://www.pureiscbd.com

Chanelle McCoy Health offers a highly accredited a 15-minute antigen test kit and 10-minute finger prick antibody test kits which are CE marked and manufactured in a facility approved by the US FDA (Food and Drug Administration). These diagnostic kits are for clinical healthcare to detect COVID-19 virus and the presence of antibodies.

Independent institutions such as Imperial College London, WHO (via Erasmus centre) and the NCI The Frederick National Laboratory, US, who independently tests for the US FDA, all validated our 10-minute antibody test kit.

An application for exceptional use of a COVID-19 rapid test, to be used by members of the public for home use, was approved on the 23rd December 2020 by the Medicines and Healthcare products Regulatory Agency (MHRA), click here for details.

This approval permits the sale of the rapid antigen test kit suitable for home use in the UK.

Our Products

CBD as a Food Supplement

For more details on Pureis® Ultra Pure CBD please visit https://www.pureiscbd.com

CBD under the “Special Medicines Access Scheme”

Chanelle McCoy Health has the capability to supply CBD under the Special Medicine Access Scheme. We can supply our products under pharmaceutical GMP conditions and have the necessary special licence.

Chanelle McCoy Health makes available unlicensed medicines to customers on the basis that they have a prescription for a CBD product and that there is a special clinical need for a particular formulation.

For more information please email info@chanellemccoyhealth.com

 

COVID-19 diagnostic Kits and Testing Regimes

Chanelle McCoy Health are the distributors for a 10-minute antibody and 15-minute antigen diagnostic tests which are CE marked and manufactured in a facility approved by the US FDA (Food and Drug Association).

We want to help manage COVID-19 risk and spread in your organisation with our quick diagnostic testing kits and testing regime. A simple prick test is all that is required to diagnose active COVID-19 infections, facilitating appropriate containment measures and reducing further spread of disease.

We have designed a testing regime comprising of an initial screening process using an accurate 10-minute antibody test to determine COVID-19 infection and the presence of antibodies, those that have a negative result can be tested with a 15-minute antigen test and or PCR.

  • All data is linked to a security-controlled app known as a digital V-Health Passport to assure the validity of the results and has the ability to contract trace.
  • It is important to note that there is no test or no testing regime that is 100% effective to rule out the presence of COVID-19.

Please contact us on the following information to hear about our available Testing Regimes.

e: info@chanellemccoyhealth.com

t: +353 (0) 90 968 4881

These programmes are not intended to replace or add to the national testing programme.

If a positive result is obtained– the concerned individual should liaise with his/ her local GP and follow the national testing programme guidelines.

Antigen Test

This is a test that detects DNA of the virus meaning potentially you could detect COVID-19 from day one of infection.

Our 15-minute antigen test kit has been assessed and passed by Public Health England. There are only 3 antigen kits to have made this approval list.

An application for exceptional use of a COVID-19 rapid test, to be used by members of the public for home use, was approved on the 23rd December 2020 by the Medicines and Healthcare products Regulatory Agency (MHRA), click here for details.

This approval permits the sale of the rapid antigen test kit suitable for home use in the UK.

The antigen test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 nasopharyngeal swab (detection of the virus).

Benefits:

  • Rapid testing for SARS-CoV-2 antigen within 15 minutes
  • Facilitates patient treatment decisions quickly
  • Simple, time-saving procedure
  • All necessary reagents provided & no equipment needed
  • High sensitivity and specificity.

Our 15-minute Antigen kit compares with PCR, 

Relative sensitivity is 97.3%,

Relative specificity is 100%, 

Accuracy is 99%

Sensitivity is “how well does the test pick up the disease”

Specificity is “how well does the test exclude other diseases”

Accuracy “how well it measures the disease”

Please note our 15 minutes antigen kit does not differentiate between SARS-CoV and SARS-CoV-2.

Please contact us on the following information to hear about our available Testing Regimes.

e: info@chanellemccoyhealth.com

t: +353 (0) 90 968 4881

These programmes are not intended to replace or add to the national testing programme.

If a positive result is obtained– the concerned individual should liaise with his/ her local GP and follow the national testing programme guidelines.

Antibody Test

This is a test that detects for antibodies a person may develops in response to a COVID-19 infection.

Our antibody test kits are widely used:

  • Our 10-minute antibody kit is used by the Australian Health Authorities, Spanish Health Authorities, French Health Authorities, South African Authorities and Chinese Health Authorities.
  • Our 10-minute antibody kits are being used commercially by private companies in the US, Spain, France, Japan, Brazil, Middle East, Africa and UK.
  • (UK hospitals such as Oxford and St Bartholomew’s Hospital)

We have independently tested our 10-minute antibody test kits with 8 independent institutions to prove our results are accurate.

Such independent institutions include for example, (papers available to show validation):

  • Imperial College London,
  • Université de Paris, Département des Agents Infectieux, France,
  • Swedish Research Council, Sweden
  • WHO
  • NCI The Frederick National Laboratory, US, whom advises the FDA

Our 10-minute antibody kit is a lateral flow immunochromatographic assay (LIA) which is a diagnostic test that detects antibodies of IgG and IgM.

The diagnostic test provides results for two scenarios:

  1. If you currently have COVID-19
  2. If you had COVID-19
  • If IgM is detected, the subject is infected with COVID-19.
  • If IgG is detected it means the subject has been infected at some point and they have subsequently developed antibodies.
  • If both antibodies are detected, it means the subject is in the recovery phase.

Our 10-minute antibody kit external validation results

  • Specificity of IgG is 98%
  • Specificity for IgM is 100%
  • Sensitivity for IgG is 97%
  • Sensitivity for IgM is 100%
  • Accuracy for IgM is 100%
  • Accuracy for IgG is 98.5%

Sensitivity is “how well does the test pick up the disease”

Specificity is “how well does the test exclude other diseases”

Accuracy “how well it measures the disease”

Please contact us on the following information to hear about our available Testing Regimes.

e: info@chanellemccoyhealth.com

t: +353 (0) 90 968 4881

These programmes are not intended to replace or add to the national testing programme.

If a positive result is obtained– the concerned individual should liaise with his/ her local GP and follow the national testing programme guidelines.

Our Founders

Chanelle McCoy

M.A., B.Sc. Management
Founder & CEO

Chanelle, Lady McCoy, MA, BSc Management, led Chanelle Medical – part of the multi-million-pound global company Chanelle Pharma, based in Galway, Ireland – for 18 years. The business is now Ireland’s largest indigenous pharma company, employing 550+.

Chanelle had responsibility for penetrating 96 markets and achieving multiple product licences. Having left to pursue other pharma opportunities, Chanelle is still a shareholder in Chanelle Pharma. She was awarded the All Ireland Business Champion Award 2018 for her outstanding achievements in business leadership; was a dragon investor on the TV series Dragons’ Den; and recently ranked “number 23 in the 50 incredible people shaping modern Ireland”

Caroline Glynn

B.Sc., MSc., L.LM
Co-Founder & CSO

Caroline Glynn, BSc, MSc, LLM, qualified with a degree in Pharmacology, a master’s in Biomedical Science, and a master’s in Law. Her scientific and legal background complements in driving and growing pharmaceutical companies.

She held several senior global positions before taking the reins of Medical Commercial Director in Chanelle Pharma, with a focus on driving the scientific and commercial innovation needed to have a transformational growth in Chanelle Pharma human business, achieving year on year growth.

Our Values

Values before Dollars

The essence of our values are looking after you with the safest, highest quality product; profit is secondary.

#You1stDollars2nd

Safety

We have invested financially and with love in multiple clinical trials to prove our product is absolute safe for you.

#MultipleClinicalTrials

Trust Matters

We enjoy going above and beyond to earn your trust.

#EarnYourTrust

Empathy, We Care

We have put ourselves in your shoes, and we really care.

#InYourShoes

Respect

Our consumers, suppliers, team…

#WeListenMoreThanWeSpeak

Quality & Science

We have invested many years of research into breaking new ground in the world of CBD, supported by science.

#NewScience

Our Motivation

Hearing about people struggling to access CBD, or having to leave their shores to get access to CBD in countries that had regulated its use, these stories really resonated with us.

In 2015, we started to research CBD, and this led us to set up Chanelle McCoy Health, an R&D-led pharmaceutical company. We knew there was an unmet need for a pure, safe, quality assured CBD product backed by clinical studies. This was where our journey began.

Another recent struggle that would resonate with us greatly again came in the form of COVID-19 where our daily lives were put on hold. With our extensive network we researched and worked diligently to provide a solution in the hope to open the economy safely without compromising on people’s health.

Our Commitment to Quality

Quality is paramount in us delivering our promises to you. This is why all we offer are produced and manufactured under the stringent quality control procedures, all Good Manufacturing Practice (GMP) certified. GMP is a requirement for medicines and certified by each country regulatory authority. Our CBD products are produced in UK Medicines and Healthcare products Regulatory Agency (MHRA) and EU approved facilities, all operating under GMP conditions.

Our diagnostic devices comply to the quality standard of ISO 13485, pertaining to medical devices. All of our devices are CE marked in accordance with In vitro Diagnostic Medical Device Directive.

This means that you can have complete TRUST in our high quality, fully compliant products, supported by science. If you would like to receive more information, please contact our office on +353 87 962 6181.